Explore. Discover. Connect.
Welcome to the world’s largest, living ecosystem of global real-world data and evidence for the life sciences and healthcare communities.
Discover the power of TriNetX, the largest global source of real-world data, as we revolutionize drug development and medical research. Beyond merely providing data, we offer end-to-end support throughout the drug development lifecycle. Our extensive research capabilities empower researchers to publish groundbreaking findings in prestigious medical journals while leveraging our platform technologies, integrated analytics, and downloadable data sets. From optimizing clinical trial designs to refining post-market safety measures, we offer comprehensive solutions that drive innovation and elevate healthcare standards worldwide. Join us in shaping a safer, healthier future, where every data point contributes to better patient outcomes and medical advancements.
Empowering Global Research: Leading the Way in Real-World Data for Comprehensive Drug Development
Enhance Study Feasibility
Evaluate criteria, comparators, and endpoints based on real-world data spanning domains from diagnoses to genomic variants. Leverage insights from real-world data (rwd) and real-world evidence (rwe) studies to enhance drug development and learn about real-world medicine and health. Test criteria against patients receiving care now.
Streamline Trial Site Collaboration
Utilize real-world data (RWD) and real-world evidence (RWE) to identify potential clinical trial sites and facilitate connections between sponsors and healthcare organizations serving patients seeking care.
Generate RWE & Unlock Insights
Answer questions of safety, efficacy, and value for all your stakeholders, from patients to regulators. Benefit from expert evidence strategists for optimized solutions leveraging real-world data to generate the insights for healthcare systems and clinical research.
Mitigate Drug Safety Signals
Discover the next generation of pharmacovigilance. Combine harmonized drug safety data from public sources with EHR and claims to enhance signaling algorithms for drug safety.
Expanding the boundaries of research and care
Hear how TriNetX power users at Sanofi, the Medical University of South Carolina, and the University of Arkansas for Medical Sciences are conducting more, and more informed, research.
Real-world data and evidence that runs a mile wide…
patient lives
healthcare organizations providing continuous, comprehensive, up-to-the-month data
countries in North and South America, EMEA, and Asia-Pacific
…and a mile deep.
date- and patient-specific clinical observations available for download
lab results in the typical record of U.S. and EMEA patients
years of clinical history on more than 40 million patients around the globe
Navigate an ocean of clinical data your way.
TriNetX Insights
VUD Names TriNetX as Its Recommended Research Platform
Partnership to Accelerate Clinical Research Innovation Across German Association of 34 University Hospitals
COVID-19 Research Published in The Lancet Rheumatology Finds Rheumatic Disease Patients are at a Reduced Likelihood of Severe Outcomes Now vs. Early Days of Pandemic
Researchers at Massachusetts General Hospital and Harvard Medical School using de-identified real-world data from TriNetX found decreased risk of hospitalization and death over time for rheumatic disease patients suffering from COVID-19
Scotland’s NHS Greater Glasgow and Clyde Health Board Seeks Better Use of Data and Increased Participation in Clinical Trials by Joining TriNetX Network
NHS Greater Glasgow and Clyde Health Board (NHSGGC), the largest NHS organization in Scotland and one of the largest in the UK, has joined the TriNetX global health research network to better leverage its extensive patient data and to promote its participation in clinical trials and research.